Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3179359

O=C(CNc1ccc(-c2ccc(F)cc2)nc1)N1CCCC1.O=C(O)C(F)(F)F

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 2/20 0.48
ADRA2A P08913 1/20 0.48
ADRA2B P18089 1/20 0.48
KCNH2 Q12809 1/20 0.48
HTR4 Q13639 1/20 0.48
GRIN2B Q13224 7/20 0.47
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
HDAC1 Q13547 2/20 0.45
HDAC2 Q92769 2/20 0.45
PTPN1 P18031 1/20 0.44
PTPN6 P29350 1/20 0.44
PTPN11 Q06124 1/20 0.44
RAB9A P51151 3/20 0.43
ALDH1A1 P00352 2/20 0.43
HTR2C P28335 1/20 0.42
MCHR1 Q99705 1/20 0.42
KDM4E B2RXH2 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3174860 0.99 ADRA2A (0.49) EGLN1ADRA2AADRA2BKCNH2HTR4
SCHEMBL8446323 0.93 ADRA2A (0.53) EGLN1ADRA2AADRA2BKCNH2HTR4
SCHEMBL8459936 0.92 ADRA2A (0.54) EGLN1ADRA2AADRA2BKCNH2HTR4
Trifluoroacetic Acid SCHEMBL3179461 0.85 PTPN1 (0.51) EGLN1ADRA2AADRA2BKCNH2HTR4
Trifluoroacetic Acid SCHEMBL3174133 0.83 GRIN2B (0.46) GRIN2BRAB9AALDH1A1NPC1
Trifluoroacetic Acid SCHEMBL3171698 0.80 MMP2 (0.47) GAAHPGDRAB9AALDH1A1KDM4E
Trifluoroacetic Acid SCHEMBL3173811 0.79 GAA (0.47) GAAHPGDRAB9AALDH1A1KDM4E
Trifluoroacetic Acid SCHEMBL3179280 0.78 MMP2 (0.47) GAAHPGDRAB9AALDH1A1KDM4E
SCHEMBL8460600 0.75 GRIN2B (0.47) GRIN2BGAAHPGDRAB9AALDH1A1
Trifluoroacetic Acid SCHEMBL3184084 0.74 KDM4E (0.47) HDAC2PTPN1PTPN6PTPN11KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188291-B2 Heteroaryl-substituted carboxamides and their use as pharmaceuticals SANOFI-AVENTIS (FR) 2012-05-29 US disclosed
US-20100016337-A1 HETEROARYL-SUBSTITUTED CARBOXAMIDES AND THEIR USE AS PHARMACEUTICALS SANOFI-AVENTIS (FR) 2010-01-21 US disclosed
EP-1939181-A1 Heteroaryl-substituted carboxamides and use thereof for the stimulation of the expression of NO synthase sanofi-aventis (FR) 2008-07-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100016337-A1 HETEROARYL-SUBSTITUTED CARBOXAMIDES AND THEIR USE AS PHARMACEUTICALS TBXAS1, PTGIS, NOS2 EGLN1 148/4885ADRA2A 554/4885ADRA2B 674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.